EnteroMedics Cut By Roth Capital On Utilization Growth

By: via Benzinga
Roth Capital Partners analyst Chris Lewis has downgraded EnteroMedics Inc (NASDAQ: ETRM) shares to a Neutral rating from Buy citing lack ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.